Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
NCT06474091 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-16
Summary
This study explores the potential value of a new blood test approach to detect measurable residual disease or early recurrence/progression in patients with cholangiocarcinoma.
Conditions
Interventions
- OTHER
-
Non-Interventional Study
Non-Interventional Study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Nguyen H. Tran, MD · Mayo Clinic in Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-08
- Primary Completion
- 2029-05-08
- Completion
- 2029-05-08
Countries
- United States
Study Locations
More Related Trials
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins
NCT01872130 ·Status: COMPLETED
-
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
NCT06409013 ·Status: RECRUITING
-
T1 Squamous Cell Carcinomas of the Lip
NCT05610293 ·Status: UNKNOWN
-
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
NCT06217874 ·Status: RECRUITING
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination
NCT05935995 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Versatile Ampification Single-Molecule Detection in Liquid Biopsy
NCT05940311 ·Status: RECRUITING
-
Molecular Screening for Cancer Treatment Optimization
NCT01566019 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT05708599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Molecular Epidemiology of Biliary Tree Cancers
NCT05179486 ·Status: RECRUITING
-
Multi-Cancer Detection Observational Cohort Study
NCT06962995 ·Status: RECRUITING
-
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
NCT01334008 ·Status: COMPLETED ·Phase: NA
-
Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples
NCT06651346 ·Status: NOT_YET_RECRUITING
-
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
NCT05473507 ·Status: ACTIVE_NOT_RECRUITING
-
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07176962 ·Status: RECRUITING
-
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT06905262 ·Status: RECRUITING
-
AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma
NCT05817279 ·Status: RECRUITING
-
Cohort Study of Pancreatic Cancer Risk
NCT04247503 ·Status: ACTIVE_NOT_RECRUITING
-
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913 ·Status: COMPLETED
-
Intravital Microscopy in Human Solid Tumors
NCT03823144 ·Status: RECRUITING ·Phase: NA
-
Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas
NCT05783973 ·Status: UNKNOWN
-
Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA
NCT06606366 ·Status: RECRUITING ·Phase: NA